Patient support made easier

With our robust patient support and savings program, your eligible patients have 2 ways to pay as little as a  $0 Copay on their MIEBO prescription.

How it works:

computer screen icon

STEP 1:

E-prescribe MIEBO to BlinkRx U.S. Boise, Idaho, from your EMR dropdown or send scripts by phone or fax.

cell phone icon

STEP 2:

BlinkRx will contact your patients with a confidential text (usually within 15 minutes), determine their copay, assist with prior authorizations, and apply any available savings offers for eligible patients. The patient then pays online or by phone.

delivery truck icons

STEP 3:

Your patient’s MIEBO is delivered—shipping is free.

Prescribe through your EMR to BlinkRx U.S. Boise, Idaho.

Contact BlinkRx by phone at 1-833-914-3856 or fax at 1-866-585-4631

OR

The MIEBO Copay Card is here to help your patients start saving

MIEBO Copay Card

Eligible commercially insured patients may pay as little as a

$0 Copay

Interested in the copay card? Your patients can download or activate their copay card in a matter of minutes.

ACTIVATE OR DOWNLOAD NOW

*Terms and Conditions apply. This offer is only valid for eligible patients with commercial insurance. This offer is not valid for patients whose prescriptions are reimbursed by any federal or state healthcare program, including Medicaid, Medicare, TRICARE, or any other federal or state healthcare program. This offer is valid in the US only. Patients may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Please see MIEBO.copaysavingsprogram.com for eligibility criteria and full Terms and Conditions.

Making MIEBO more accessible across coverage types†

E-scribe to BlinkRx or provide your patients with the MIEBO Copay Card for use at retail pharmacies to receive the following benefits

Commercially Insured
COVERED
(1st Fill & Refills)		 $0 for 30-, 60-, or 90-day supply and subsequent refills
NOT COVERED
(1st Fill‡)		 $0 for 30-day supply
Refills‡
(Covered)		 If PA is submitted & approved:
  • $0 per subsequent 30-day refill
Refills‡
(Not Covered)
If PA is submitted & denied:
  • $29 per subsequent 30-day refill
If PA is NOT submitted:
  • $250 per subsequent 30-day refill

MIEBO Copay Card activation

  • Patients must activate copay card before using at pharmacy
  • Copay card and activation are not required when using BlinkRx

‡PA support

  • Copay card at retail: PA must be submitted through PARx for patient to be eligible for MIEBO at $29
  • BlinkRx: PAs can be submitted through CMM or PARx for patient to be eligible for MIEBO at $29
GOVERNMENT INSURED (Including Medicare)
COVERED
(1st Fill & Refills§)		 Patient’s plan copay for 30-, 60-, or 90-day supply, and subsequent refills
NOT COVERED
(1st Fill & Refill) 		If PA is approved:
  • Patient’s plan copay

For not covered patients filling MIEBO through BlinkRx

  • If PA determination has not been made or not approved 2 days after PA initiation, patient is eligible for 30-day product bridge
  • 1 additional 30-day product bridge if appeal is not approved
UNINSURED
(Non-government)
CASH PAY $250 for 30-day supply and subsequent refills

CMM, CoverMyMeds; PA, prior authorization.

MIEBO patients with a high deductible may pay ~$225 per 30-day supply and subsequent refills until deductible is met.

†Terms and Conditions apply. See Eligibility Criteria/Terms and Conditions at MIEBO.blsavingscard.com.

§Copay card is not applicable for covered government patients.

Only for patients under age 65.

blinkrxresources

Image of BlinkRx Patient Instruction Tearpad Image of BlinkRx Patient Instruction Tearpad
BlinkRx Patient Instruction Tearpad (Commercial and Government)

These resources inform patients about BlinkRx and what to expect when you send your patient prescriptions through this program. There are 2 versions: one for commercial patients under 65 and one for government patients (including those covered by Medicare Part D).

Image of BlinkRx Fax Form Image of BlinkRx Fax Form
BlinkRx Fax Form

This form is used to e-prescribe MIEBO to BlinkRx. For more details, see BlinkRx information above.

BlinkRx ECP Leave Behind BlinkRx ECP Leave Behind
BlinkRx ECP Leave Behind

Learn how to prescribe through BlinkRx and explore a brief overview of how BlinkRx can help patients with their MIEBO prescriptions.

Savings & Resources inside droplet

UP NEXT

Resources

arrow-circle-right
 
 
*Required fields.

By submitting your information, you consent to receive communications containing information and educational resources about MIEBO, as well as other communications from Bausch + Lomb. By submitting your information, you confirm that you have read and agree with the terms of our Privacy Policy and Legal Notice.

INDICATION

MIEBO® (perfluorohexyloctane ophthalmic solution) is indicated for the treatment of the signs and symptoms of dry eye disease.

IMPORTANT SAFETY INFORMATION

  • MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO
  • Instruct patients to instill one drop of MIEBO into each eye four times daily
  • The safety and efficacy in pediatric patients below the age of 18 have not been established
  • The most common ocular adverse reaction was blurred vision (1% to 3% of patients reported blurred vision and conjunctival redness)

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for full Prescribing Information for MIEBO.

Expand Expand Expand Expand

INDICATION AND IMPORTANT
SAFETY INFORMATION

INDICATION

MIEBO® (perfluorohexyloctane ophthalmic solution) is indicated for the treatment of the signs and symptoms of dry eye disease.

IMPORTANT SAFETY INFORMATION

  • MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO
  • Instruct patients to instill one drop of MIEBO into each eye four times daily
  • The safety and efficacy in pediatric patients below the age of 18 have not been established
  • The most common ocular adverse reaction was blurred vision (1% to 3% of patients reported blurred vision and conjunctival redness)

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for full prescribing Information for MIEBO.